Technical Analysis for MLND - Millendo Therapeutics, Inc.

Grade Last Price % Change Price Change
grade A 14.69 1.73% 0.25
MLND closed up 1.73 percent on Friday, March 22, 2019, on 1.66 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical MLND trend table...

Date Alert Name Type % Chg
Mar 22 Upper Bollinger Band Walk Strength 0.00%
Mar 22 Earnings Movers Other 0.00%
Mar 22 Wide Bands Range Expansion 0.00%
Mar 22 Overbought Stochastic Strength 0.00%
Mar 21 Spinning Top Other 1.73%
Mar 21 Upper Bollinger Band Walk Strength 1.73%
Mar 21 Earnings Movers Other 1.73%
Mar 21 Outside Day Range Expansion 1.73%
Mar 21 Wide Bands Range Expansion 1.73%
Mar 21 Overbought Stochastic Strength 1.73%

Older signals for MLND ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Millendo Therapeutics is a late-stage biopharmaceutical company focused on developing novel treatments for orphan endocrine diseases where current therapies do not exist or are insufficient. The Company’s objective is to build a leading endocrine company that creates distinct and transformative treatments for a wide range of endocrine diseases where there is a significant unmet medical need. The Company is currently advancing livoletide for the treatment of Prader-Willi syndrome and nevanimibe for the treatment of classic congenital adrenal hyperplasia and endogenous Cushing’s syndrome.
Organ Systems Endocrine System Late Stage Biopharmaceutical Cushing's Syndrome Adrenal Gland Disorders Endocrine Diseases Prader Willi Syndrome
Is MLND a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 15.15
52 Week Low 6.77
Average Volume 15,025
200-Day Moving Average 11.6033
50-Day Moving Average 11.3773
20-Day Moving Average 12.8435
10-Day Moving Average 13.58
Average True Range 0.8317
ADX 36.17
+DI 25.824
-DI 8.3489
Chandelier Exit (Long, 3 ATRs ) 12.4049
Chandelier Exit (Short, 3 ATRs ) 13.5051
Upper Bollinger Band 14.8417
Lower Bollinger Band 10.8453
Percent B (%b) 0.96
BandWidth 31.116129
MACD Line 0.8984
MACD Signal Line 0.7434
MACD Histogram 0.155
Fundamentals Value
Market Cap 524.27 Million
Num Shares 35.7 Million
EPS -2.11
Price-to-Earnings (P/E) Ratio -6.96
Price-to-Sales 116.65
Price-to-Book 0.67
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.80
Resistance 3 (R3) 15.73 15.28 15.62
Resistance 2 (R2) 15.28 15.00 15.32 15.55
Resistance 1 (R1) 14.99 14.83 15.14 15.06 15.49
Pivot Point 14.54 14.54 14.62 14.58 14.54
Support 1 (S1) 14.25 14.26 14.40 14.32 13.89
Support 2 (S2) 13.80 14.09 13.84 13.83
Support 3 (S3) 13.51 13.80 13.77
Support 4 (S4) 13.58